4/7
09:15 pm
okur
Form 3 OnKure Therapeutics, For: Mar 31 Filed by: Blavatnik Len
Medium
Report
Form 3 OnKure Therapeutics, For: Mar 31 Filed by: Blavatnik Len
4/7
09:14 pm
okur
Form SCHEDULE 13D OnKure Therapeutics, Filed by: AI Biotechnology LLC
Medium
Report
Form SCHEDULE 13D OnKure Therapeutics, Filed by: AI Biotechnology LLC
4/7
07:22 pm
okur
Form SCHEDULE 13G OnKure Therapeutics, Filed by: StepStone Group LP
Medium
Report
Form SCHEDULE 13G OnKure Therapeutics, Filed by: StepStone Group LP
4/7
04:31 pm
okur
Form SCHEDULE 13G OnKure Therapeutics, Filed by: Trails Edge Capital Partners, LP
Low
Report
Form SCHEDULE 13G OnKure Therapeutics, Filed by: Trails Edge Capital Partners, LP
4/7
04:14 pm
okur
Form SCHEDULE 13G OnKure Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Low
Report
Form SCHEDULE 13G OnKure Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
4/3
03:29 pm
okur
Form 4 OnKure Therapeutics, For: Apr 01 Filed by: Saccomano Nicholas A
Medium
Report
Form 4 OnKure Therapeutics, For: Apr 01 Filed by: Saccomano Nicholas A
4/3
03:28 pm
okur
Form 4 OnKure Therapeutics, For: Apr 01 Filed by: Leverone Jason A.
Medium
Report
Form 4 OnKure Therapeutics, For: Apr 01 Filed by: Leverone Jason A.
4/3
03:26 pm
okur
Form 4 OnKure Therapeutics, For: Apr 01 Filed by: Hartley Dylan
Medium
Report
Form 4 OnKure Therapeutics, For: Apr 01 Filed by: Hartley Dylan
4/3
03:25 pm
okur
Form 4 OnKure Therapeutics, For: Apr 01 Filed by: Agresta Samuel
Medium
Report
Form 4 OnKure Therapeutics, For: Apr 01 Filed by: Agresta Samuel
4/1
05:26 pm
okur
Form 4 OnKure Therapeutics, For: Mar 31 Filed by: Ratcliffe Liam
Medium
Report
Form 4 OnKure Therapeutics, For: Mar 31 Filed by: Ratcliffe Liam
4/1
05:24 pm
okur
Form 3 OnKure Therapeutics, For: Mar 31 Filed by: Ratcliffe Liam
Medium
Report
Form 3 OnKure Therapeutics, For: Mar 31 Filed by: Ratcliffe Liam
4/1
11:17 am
okur
Form SCHEDULE 13G OnKure Therapeutics, Filed by: ACORN BIOVENTURES, L.P.
Low
Report
Form SCHEDULE 13G OnKure Therapeutics, Filed by: ACORN BIOVENTURES, L.P.
3/30
06:07 am
okur
Form 8-K OnKure Therapeutics, For: Mar 27
Low
Report
Form 8-K OnKure Therapeutics, For: Mar 27
3/24
06:58 pm
okur
Form 4 OnKure Therapeutics, For: Mar 23 Filed by: Saccomano Nicholas A
Low
Report
Form 4 OnKure Therapeutics, For: Mar 23 Filed by: Saccomano Nicholas A
3/24
06:56 pm
okur
Form 4 OnKure Therapeutics, For: Mar 23 Filed by: Leverone Jason A.
Low
Report
Form 4 OnKure Therapeutics, For: Mar 23 Filed by: Leverone Jason A.
3/12
04:24 pm
okur
Form S-8 OnKure Therapeutics,
Medium
Report
Form S-8 OnKure Therapeutics,
3/12
04:11 pm
okur
Form 10-K OnKure Therapeutics, For: Dec 31
Medium
Report
Form 10-K OnKure Therapeutics, For: Dec 31
3/12
04:06 pm
okur
Form 8-K OnKure Therapeutics, For: Mar 12
Medium
Report
Form 8-K OnKure Therapeutics, For: Mar 12
2/17
08:15 pm
okur
Form SCHEDULE 13G OnKure Therapeutics, Filed by: ADAR1 Capital Management, LLC
Low
Report
Form SCHEDULE 13G OnKure Therapeutics, Filed by: ADAR1 Capital Management, LLC
2/17
04:54 pm
okur
Form SCHEDULE 13G/A OnKure Therapeutics, Filed by: CITADEL ADVISORS LLC
Medium
Report
Form SCHEDULE 13G/A OnKure Therapeutics, Filed by: CITADEL ADVISORS LLC
2/17
04:12 pm
okur
Form SCHEDULE 13G/A OnKure Therapeutics, Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Medium
Report
Form SCHEDULE 13G/A OnKure Therapeutics, Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
1/30
02:22 pm
okur
Form SCHEDULE 13G/A OnKure Therapeutics, Filed by: VANGUARD GROUP INC
Low
Report
Form SCHEDULE 13G/A OnKure Therapeutics, Filed by: VANGUARD GROUP INC